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Sma_ Short-term cultures from 12 non-squamous ceD carcnomas (NSCCs) of the head and neck were
cytoseneticaly investigted. Three tumours were acinic cell two adenoid cystiarcino three
mucoelidermoid carcinas, two carcInOMa in plemorphic n a, and two ade ainomas. Clonal
chromosome aberrations were in al but one adenocarcinoma. our data, a total of 40 head
and neck NSCCs with donal aberrations have been described. Deletions of the arm ofchromosome 6 are
the most common aberrations (11/40 cases); they have b detected in all types ofNSCC except Mi
peomorphic adenoma. Two aberration soFm to be closely aociated with tumour type:
t(6;9Xq2l-24,p13-23), which has been seen in three of 11 adenoid cystic as (in two as the sole
aberration), and suctural of 8q12-13, which have been detected in three of four a
in pleomorphic adenoma.
Non-squamous cell carcinomas (NSCCs) account for 5-10%
Of malinant head and neck tumours. Previous karyotypic
information on these neoplasms is restricted to 30 cases with
clonal aberrations: 11 with numerical changes only and 19
tumours with structural aberrations (Mark et al., 1981, 1991,
1992; Stenman et al., 1982, 1986, 1989; Stenman & Mark,
1983; Sandros et al., 1988; Bulkerdiek et al., 1990; Higashi et
al., 1991a,b; Nordkvist et al., 1992). Apart from one tumour
originaig from the minor salivary glands of the nasal
cavity, all have been located in major salivary glands. We
herein present the cytogenic findings in 12 NSCCs, 11 of
which had clonal chromosome aberrations.
Materas and -bos
Head and neck NSCCs from 12 patients were cytogenetically
analysed (Table I). The following tumour types were
represented: three acinic cell carcnomas, two adenoid cystic
carcinomas (both with cribriform/trabeular histology), three
mucoepidermoid carcnomas, two carcinomas in pleomorphic
adenoma and two adenocarcinomas.
The primary lesion was studied in eight cases and regional
metastases in three (cases 1-3). One patient (no. 9) was
studied both at the time when primary malignancy was diag-
nosed and 1 year later, when a local recurrence occurred.
Except for the second analysis of patient 9, none of the
patients had received cytotoxic therapy prior to cytogenic
analysis. From one patient (no. 6), samples for cytogenic
analysis were obtained both from a diagnostic biopsy and, 1
month later, from the excised tumour. All tumour specimens
were divided into two parts: one for histopathological
examination, the other for cytogenetic analysis.
The culture methods have been described in detail
previously (Jin et al., 1988, 1993). In brief, the fresh samples
were mince disaggreted overnight in collagenase and
plated on collagen-coated chamber sLdes or in culture flasks
either in RPMI-1640 medium supplemented with 17% fetal
calf serum, glutamine, insulin, epidermal growth factor,
cholera toxin and antibiotics (patients 1, 2, and 6), or in
MCDB 153 medium supplemented with 2-5% fetal calf
serum, growth factors and antibiotics. The cultures were
harvested after 5-10 days. G-banding was obtained with
Wright's stain. The clonality criteria and the description of
karyotypes were according to the ISCN (1991).
ReqAs
Clonal chromosome abnormalities were detected in 11
tumours (Table I). The major karyotypic features of the
different tumor types were as follows.
All three acinic cell carcinomas (patients 1-3) had
cytogenetically unrelated clones with pseudo- or near-diploid
chromosome numbers. The only recurrent anomaly was
trisomy 7, found in two tumours. Patient 3 had one clone
with structural rearrangement of 6q21.
Both adenoid cystic carcinomas (patients 4 and 5) dis-
played donal structural abnormalities. Rearrangements
affecting band 6q21 were found in both tumours. Patient 4
had two related clones. One was hypodiploid with a recip-
rocal t(6,9Xq21-22;pl3-21) (Figure 1), a three-way trans-
location between chromosomes 3, 4 and 10 and loss of the Y
chromosome. The second clone was hypotetraploid with all
rearranged chromosomes in duplicate. Patient 5 had a
del(6Xq21) together with a supernumerary ring chromosome
and numerical changes (Figure 2).
All three mucoepidermoid carcinomas (patients 6-8) had
clonal structural aberrations. Both samples from patient 6
revealed the same abnormalities, a hypodiploid clone with
unbalanced rearrangements involving chromosomes 4, 10 and
22 and a balanced t(11;13). Patient 7 had a supernumerary
ring chromosome as the sole anomaly. The third tumour
(patient 8) had del(6Xq21) as the sole clonal change.
Clonal rearrangements were detected in both carcinomas in
pleomorphic adenoma (patients 9 and 10). Patient 9 was
investigated twice. The first cytogenetic analysis revealed
three related clones (Higashi et al., 1991a). A supernumerary
ring chromosome was present in all three clones, in one of
them as the sole change. The examination of the recurrent
tumour showed two clones that were unrelated to each other
and to the clones of the primary tumour. The tumour of
patient 10 had a pseudotetraploid clone with a reciprocal
translocation, t(8;9)(ql2,q21), in duplicate as the sole struc-
tural anomaly (Figure 3).
One adenocarcinoma had a normal karyotype. The other
tumour (patient 12) had a del(6)(q21) together with a super-
numerary nng chromosome as the only anomalies.
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Table I Cytogenetic and clinical data in 12 carcinomas of the lacrimal and salivary glands
Patient TNM classification/
no. Agelsex statusa Site Karyotype
Acinic cell carcinoma
I 48/F rTO NI MO/M Parotid gland 47,XX,+7 [22/47,XX,+ 18 [2/46,XX,del(4XqI2) [2/46,XX [21]
2 76/F rTO N2b MO/M Parotid gland 47,XX,+12 [2/48,XX,+7,+12 [21148,XXt(1;19Xq25,pl3),+8,+9 [2/46,XX [15]
3 75/M rTIb NI MO/M Parotid gland 45,X,-Y [51/47,XY,+Y [8V46,XY,t(1;6)q21;q21) [21/47,XY,t(12;16Xql5;q22),+16
[21/46,XY [4]
Adenoid cystic carcinoma
4 66/M T2 NO MO/P Larynx 45,X,-Y,t(3;10-,4Xq2I;q26;q21),t(6;9)q21-22,-pl3-21) [6]/90,idemx2 [81/46,XY [3]
5 71 F T4 NO MO/P Retromolar 46,XX,del(6)q21),-11,-14,+22,+r [391/46,XX [5]
trigone
Mucoepidermoid carcinoma
6 38/M TI NO MO/P Epipharynx 45,XY,der(4)t(4;22XpI4;qI 1),dic(10;22XpI I;q I1),t(11;I3Xq24;q12),-22
[211/46,XY[3]
38 TI NI MO/P Epipharynx 45,XY,der(4)t(4;22)(pl4;qll),dic(10;22)(jpl;qll),t(l1;133Xq24;ql2),-22 [71/46,XY[6]
7 72/M T2a NO MO/P Parotid gland 47,XY,+r [111/46,XY [10]
8 83/F /P Submandibular 46,MX,del(6)q2I) [2/46,XX [27]
gland
Carcinoma in pleomorphic adenoma
9 52/P IP Lacrimal gland 46,X,-X,+r [81/47,)X,,-5, +der(9)t(8;?,9Xql 3;?,-p22),+rj5V
47,idem,del(8)p 2),der(l 6)t(8;16XqI 3;q24) [211/46,XX [22]
53/F /R Lacrimal gland 46,X,- lde(4Xq21q25),der(7)t(7;I8)q34;q21),add(7)q22),t(9;I3)q22;q32),
inv(lOXqI lq22),t(I 1;20XqI3;q1 1),jns(I2;12;12XqI5;q22q24),add(18Xq21), +mar
[151V46,deI(X)(q24),-X,t(1; I1)(p32;q23),add(1)(p22),add(20)(pI 1),+der(.)t(I;?;5)
(p22;?;q13),+mar [3]
10 80/M Tla NO MO/P Parotid gland 92,XXYY,t(8,9Xql2;q21)x2 [31]
Adenocarcinoma
11 66/M T2 NI MO'P Parotid gland 46,XY [64]
12 75 F T3 NO MOlP Palate 47,XX,del(6Xq2l),+r [21p46,XX [4]
'P, primary; R. recurrence; M, metastasis. TNM classification according to the UICC criteria (1987). No TNM classification exists for
lacrimal and submandibular carcinomas. bPreviously reported (Higashi et al., 1991a).
Figwe 1 Representative karyogram of the adenoid cystic carcinoma of patient 4. Arrowheads indicate breakpoints. See Table I
for karyotypic description. The loss of one chromosome 6 in this metaphase was non-clonal.44 Y. JNetal.
Figwe 2 Representative karyogram of the adenoid cystic carcinoma of patient 5. A del(6Xq21) and a supernumerary ring
chromosome were the sole structural changes. The arrowhead indicates the 6q breakpoint. The loss of one X chromosome in this
cell was non-clonal.
Fire 3 Representative karyogram of the carcinoma in pleomorphic adenoma of case 10. Arrowheads indicate breakpoints. See
Table I for karyotypic description.CHROMOSOMES IN HEAD AND NECK CARCINOMAS 45
Ilwhuding the present study, only 40 NSCCs with clonal,
acquired aberrations are known (for references, see Introduc-
tion). Nine tumours have been acinic cell carcinomas, 11
adenoid cystic carcinomas, ten mucoepidermoid carcinomas,
four carcinomas in pleomorphic adenoma and six adenocar-
cinomas. The major karyotypic features of the different
tumour types seem to be the following.
Apart from - Y, + 7 and + 8, which have been detected
in five, two and two cases, respectively, no rcurrent aberra-
tion has been found in acinic cell carcinomas. The patho-
genetic significance of - Y and + 7 in short-term cultured
neoplasms has been much debated (for review, see Johansson
et al., 1993). Suffice it here to say that we are of the opinion
that these simple numerical changes represent mutations that
have little or no impact on the genesis of head and neck
carcinomas.
Three of the acnic cell carcinomas have had structural
aberrations of 6q21-24 (Mark et al., 1981; Sandros et al.,
1988; patient 3 ofthe present report). However, in two ofthe
cases, several other, cytogenetically aberrant, clones were also
detected. Cytogenetic polyclonality has been present in six
acinic cell carcinomas and is also common in head and neck
squamous cell carcinomas and in skin tumours (e.g. Mertens
et al., 1991; Jin & Mertens, 1993). It is unknown whether this
heterogeneity indicates multicellular tumour origin or merely
reflects the accumulation of chromosome mutations in
stromal cells.
The karyotypic picture in adenoid cystic carcinomas is
more homogeneous. Three of the 11 cases have had the
reciprocal translocation t(6;9)(q21-q24;p13-23), in two
tumours as the sole aberration (Table II) (Stenman et al.,
1986; Higashi et al., 1991b; patient 4 ofthe present report). A
similar translocation has previously only been reported in
two cases of acute myeloid leukaemia (Mitelman, 1994). It is
therefore reasonable to regard this particular t(6;9) as a
primary abnormality that is specific for adenoid cystic car-
cinoma. The other recurrent aberration in this tumour type is
loss of genetic material from the long arm ofchromosome 6;
this had been reported in four cases as the sole aberration or
together with a few other rearrangements. The deletions have
been interpreted as either interstital or terminaL with break-
points assigned to 6ql6-24 (Stenman et al., 1986; Sandros et
al., 1988; patient 5 of the present report). Whether the
pathogenetically important result of the deletions is loss of
tumour-suppressor genes or the structural rearrangement ofa
gene that might be identical to the one involved in the t(6;9)
remains to be elucidated.
Deletions of distal 6q seem to be common also in
mucoepidermoid carcinomas. Two patients with del(6)(q25)
and one with del(6)(q21), always as the sole aberration, have
been described (Sandros et al., 1988; patient 8 of the present
report). This indicates that the same genetic pathway can be
involved in the genesis of this tumour type and adenoid
cystic carcinomas. No other recurrent aberration has been
detected.
Only four cytogenetically aberrant carcinomas in pleomor-
phic adenoma are known (Mark et al., 1991, 1992; patients 9
and 10 of the present report). The two tumours described by
Mark and co-workers had fairly complex karyotypes. One
had two related clones with ring chromosome 2 and
unbalanced structural aberrations involving chromosomes 7,
11 and 12 as common denominators, the other had six
related clones sharing an isochromosome 8q. In addition,
four of the clones in the latter tumour had one or two copies
of chromosome 8 with a rearrangement of band qI3. Patient
9 of the present study was investigated on two occasions. At
the age of 50 years, the patient had undergone surgery five
times because of local recurrnc of a histologically benign
pleomorphic adenoma in the left lacimal gland. When she 2
years later presented with a new recurrence, the histo-
pathological findings were compatible with malignant trans-
formation to carcinoma in pleomorphic adenoma. Cyto-
genetic analysis of that tumour showed the presence of three
related clones, with a supernumerary ring chromosome as the
primary aberration present in all of them and with
t(8;?,9)(ql3;?;p22) and t(8;16)(ql3;q24) as secondary changes
in one subclone each (Higashi et al., 1991a). In spite of
post-operative cytotoxic therapy, the patient relapsed again
after 1 year. Now two unrelated pseudodiploid clones with
multiple structural rearrangements predominated. None of
the clonal aberrations were similar to those observed at the
first anablsis. We believe that the new aberrations are the
result of the cytotoxic treatment; it is unclear whether they
reflect change in the tumour parenchyma. Our second case
of carcinoma in pleomorphic adenoma (patient 10) also had
a rearrangement of 8q. All 31 analysed metaphase cells had
the pseudottraploid karyotype 92,XXYY,t(8;9Xq12;q21) x 2.
Thus, three out of four tumours have had rearrangements of
8q12-13, which is of particular interest since this region is
also structurally rearranged in 50% of benign pleomorphic
adenomas with clonal aberrations (Bullrdiek et al., 1993). A
similar cytogenetic relationship between benign and malig-
nant tumours has previously only been described in lipogenic
tumours. Lipomas frequently show various structural rear-
rangements involving bands 12ql3-15, whereas the myxoid
liposarcomas are characterised by a t(l2l16)(ql3,plI)
(Sreekantaiah et al., 1992; Mandahl et al., 1993). Patient 10
may be partculrly illustrative with regard to the karyotypic
relationship between tumours of similar histogenesis but
different maliogncy potential. This patient had for several
years noted a tumour in the right parotid gland. The histo-
pathological analysis reval an in situ carcnoma together
with foci of pleomorphic adenoma. Although several pleo-
morphic adenomas with 8q12-13 rearrangements, seven of
Table k Deltions and translocations involving 6q in salivary gland carcinomas with structural anomalies
Tumour type Deletion Translocation Reference
Acinic cell carcinoma (3/5r del(6Xq23q24)b Sandros et al. (1988)
Adenoid cystic carcinoma (7/9)
Mucoepidermoid carcinoma (3/6)
del(6Xql6q22)b
del(6)q22)b
d&(6Xq24)
del(6Xq2l)
del(6Xq25)b
del(6)q25)b
del(6)q21)b
t46;21)(ql3;q22)p
t(l;6)q21;q21)
t(6,-9q24,p23)b
t(6,9Xq2l -22pl3-21)
t(6/9Xq2l -22,-pl3-21)
Mark et al. (1981)
Patient 3 of the present sries
Stenman et at. (1986)
Stenman et al. (1986)
Sandros et al. (1988)
Sandros et al. (1988)
Higashi et al. (1991a)
Patient 4 of the present series
Patient 5 of the present sere
Sandros et al. (1988)
Sandros et al. (1988)
Patient 8 of the present series
Adenocarcinoma (3/3) del(6)q24q25)" Sandros et al. (1988)
del(6Xq22q24)b Stenman et al. (1989)
del(6)q21) Patient 12 of the present series
aNunber of cases with 6q rearrangements/total number of cases with structural anomalies. bSole anomaly in one clone.46 Y. JIN et al.
which were involved in translocations with chromosome 9,
have been reported (Mitelman, 1994), all of these tumours
have had a pseudo- or near-diploid chromosome number. It
is tempting to speculate that the malignant transformation
was associated with, even caused by, the duplication of an
abnormal clone already present in the adenoma.
Of the six adenocarcinomas with clonal aberrations, three
cases had simple numerical changes only and three had a
single abnormal clone with a deletion of 6q (Stenman &
Mark, 1983; Sandros et al., 1988; Stenman et al., 1989; Mark
et al., 1992; patient 12 of the present report). Deletion of the
long arm of chromosome 6 is thus the most consistently
recurring aberration in salivary gland adenocarcinomas. This
aberration was found in three of the tumours, all of which
had simple karyotypic deviations.
Supernumerary ring chromosomes were frequent in our
series, being present in four out of 11 tumours with abnormal
karyotypes (36%). Two tumours (patients 7 and 9) had a
ring chromosome as the sole anomaly in at least one clone.
Two others (patients 5 and 12) had a ring chromosome
together with del(6)(q2l) as the sole structural anomalies. In
none of the tumours could the origin of the ring be
identified. Only one head and neck NSCC with a ring
chromosome has been reported; that was an r(2) in a com-
plex karyotype (Mark et al., 1992). Whether the ring forma-
tions play any pathogenetic role or occur as a consequence of
the neoplastic process is unknown. Ring chromosomes have
been reported in less than 3% of karyotypically abnormal
neoplasms (Mitelman, 1994). Among solid tumours, super-
numerary rings have been associated with borderline or low
malignant mesenchymal tumors, e.g. atypical lipomas or
highly differentiated liposarcomas (Heim et al., 1988; Man-
dahl et al., 1988a), myxoid malignant fibrous histiocytomas
(Mandahl et al., 1988b, 1989), dermatofibrosarcoma pro-
tuberans (Bridge et al., 1990; Mandahl et al., 1990; Orndal et
al., 1992) and parosteal osterosarcomas (Mertens et at.,
1993).
Although some aberrations appear to be common to
several NSCC types, others are characteristic for particular
NSCC subsets. One common denominator is deletion of 6q,
often as the sole aberration, which has been detected in 30%
of the tumours and in all subtypes except carcinomas in
pleomorphic adenoma (Table HI). The more specific aberra-
tions are t(6;9)(q21-24;pl3-23), detected so far exclusively
in adenoid cystic carcinomas, and translocations involving
8ql2-13, which seem to be strongly associated with car-
cinomas in pleomorphic adenoma. The available cytogenic
data on head and neck NSCC also indicate that the
karyotypic profile of these tumours differs from that of
squamous cell carcinomas (SCCs), the predominant tumour
type in this region. A subset of SCCs have had pseudo- or
near-diploid karyotypes with seemingly random balanced
structural rearrangements and/or numerical changes; several
arguments have been put forward to interpret these findings
with caution, as they may represent stroma cell mutations
(see, for example, Jin et al., 1993). Other SCCs have, how-
ever, had highly complex karyotypes with chromosome
numbers in the triploid range. Recurrent aberrations among
these tumours include isochromosome 8q, rearrangements of
lq13 (often as a homogeneously staining region), Robert-
sonian translocations that frequently involve chromosome 15
and loss of chromosome material from chromosome arms 3p,
7q, 8p, 1 lq and 17p as well as the short arms of the acrocen-
tric chromosomes (Jin et al.. 1993).
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